The US Department of Transportation (DOT) has dismissed a complaint filed against Southwest Airlines by four national advocacy groups, bringing an end to a closely watched dispute over airline accommodations for passengers with severe food allergies.
The complaint centered on a late-2022 policy change that temporarily removed passengers with nut allergies from Southwest’s pre-boarding group, placing them instead in a category that boarded after Group A. Advocacy groups argued that this shift made it difficult for passengers to clean seating areas and reduce the risk of allergen exposure.
Southwest maintained that the change was the result of an internal miscommunication and said it began correcting the issue before the complaint was formally filed. The airline ultimately restored affected passengers to pre-boarding eligibility by the end of 2022.
In its decision, the DOT declined to pursue enforcement action, citing the airline’s corrective steps and the unintentional nature of the policy change. The agency exercised what it described as “enforcement discretion,” effectively closing the case without penalties.
However, the ruling also clarified an important point for travelers with food allergies: while individuals with disabilities may request additional time or assistance under the Air Carrier Access Act, the existence of a disability does not automatically entitle a passenger to a specific boarding accommodation—such as pre-boarding—unless that requirement has been explicitly established by regulation.
Advocacy groups had also urged the DOT to expand formal protections to include passengers with other serious food allergies, such as dairy or shellfish. While the department acknowledged that these allergies can be just as severe as nut allergies, it declined to extend additional requirements without a formal rulemaking process.
Separately, Southwest has taken steps to improve in-flight emergency preparedness. In February 2024, the airline agreed to include epinephrine auto-injectors in its onboard medical kits, following concerns that existing supplies—typically single-dose vials requiring medical expertise to administer—may not be sufficient in a real-world emergency.
The decision highlights the current limits of federal protections for airline passengers with food allergies and underscores the need for clearer, standardized policies across the industry.
It’s important to understand the current state of air travel for individuals with severe food allergies after the DOT’s ruling:
- Pre-boarding is not guaranteed: Even for passengers with severe allergies, airlines are not automatically required to offer pre-boarding unless specific regulations mandate it.
- Policies can vary by airline: Accommodations may differ, making it important to check policies in advance and speak with gate agents.
- Self-advocacy remains critical: Families should continue to take precautions, including carrying wipes and multiple epinephrine devices.
- Progress is happening—but slowly: The addition of epinephrine auto-injectors onboard is a meaningful step, but broader protections may require formal federal rulemaking.
